...
首页> 外文期刊>American Journal of Surgical Pathology >Ovarian cellular fibromas lack FOXL2 mutations a useful diagnostic adjunct in the distinction from diffuse adult granulosa cell tumor
【24h】

Ovarian cellular fibromas lack FOXL2 mutations a useful diagnostic adjunct in the distinction from diffuse adult granulosa cell tumor

机译:卵巢细胞纤维瘤缺乏FOXL2突变,可作为区分成人弥漫性颗粒细胞瘤的有用诊断辅助手段

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Ovarian cellular fibromas are uncommon neoplasms, which may result in considerable diagnostic confusion with diffuse adult granulosa cell tumor. This is an important distinction, as the former usually exhibits benign behavior, whereas the latter is a low-grade malignant neoplasm capable of recurrence and metastasis. FOXL2 mutation (402C-G) has been demonstrated in >95% of ovarian adult granulosa cell tumors, only rarely in other ovarian sex cord-stromal neoplasms, and never in ovarian fibromas. In this study, we evaluated a series of ovarian cellular fibromas or mitotically active cellular fibromas (n=22), 3 with minor sex cord elements, for FOXL2 mutation. These were mostly received in consultation, often with a differential diagnosis of diffuse adult granulosa cell tumor. Immunohistochemically, 10 of 10 cases tested exhibited nuclear staining with FOXL2. FOXL2 (402C-G) mutation was not demonstrated in any of the 22 cellular or mitotically active cellular fibromas. Three additional neoplasms composed of cellular nodules of epithelioid cells in a background fibrous stroma, raising the possibility of adult granulosa cell tumor with a prominent fibrothecomatous component, were also tested; 2 of these were mutation negative, and 1 contained a FOXL2 mutation. FOXL2 mutation analysis is a useful adjunct in distinguishing between diffuse adult granulosa cell tumor (mutation present) and cellular fibroma (mutation absent). Mutation testing should be considered in problematic cases, as this will provide prognostic information for the patient.
机译:卵巢细胞纤维瘤是罕见的肿瘤,其可能导致与弥漫性成年颗粒细胞瘤的诊断混淆。这是一个重要的区别,因为前者通常表现出良性行为,而后者是能够复发和转移的低度恶性肿瘤。 FOXL2突变(402C-G)已在> 95%的卵巢成年颗粒细胞肿瘤中得到证实,仅在其他卵巢性索-间质肿瘤中很少见,而在卵巢纤维瘤中从未见过。在这项研究中,我们评估了一系列卵巢细胞纤维瘤或有丝分裂活性细胞纤维瘤(n = 22),其中3个具有次要的性脐带成分,以评估FOXL2突变。这些大多是接受咨询的,通常可鉴别诊断为弥漫性成人颗粒细胞瘤。免疫组织化学法检测的10例病例中有10例表现出FOXL2的核染色。 FOXL2(402C-G)突变未在任何22种细胞或有丝分裂活性细胞纤维瘤中得到证实。还测试了另外三种由背景性纤维基质中的上皮样细胞的细胞结节组成的肿瘤,这增加了成年的颗粒细胞瘤具有明显的纤维瘤成分的可能性。其中2个为突变阴性,其中1个包含FOXL2突变。 FOXL2突变分析在区分弥漫性成年颗粒细胞瘤(存在突变)和细胞纤维瘤(无突变)方面是有用的辅助工具。在有问题的情况下应考虑进行突变检测,因为这将为患者提供预后信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号